The Latest on the new FDA guidelines for weight loss surgery

The new guidelines from the Food and Drug Administration (FDA) are likely to put more weight on patients’ claims for weight reduction surgery.

The agency released a list of the medications that will be allowed for weight-loss surgery this year.

These are the most commonly used for weight control.

Some of the new medications include: B-5, citalopram, sertraline, paroxetine, nortriptyline, trazodone, fenfluramine, and zoloft.

The new guidelines do not allow medications that treat depression or anxiety.

However, some weight-control drugs have been used to treat depression in clinical trials, which will need to be reviewed by the FDA, and are being tested.

The FDA has not said how much weight-reduction surgery patients will need.

They have also not said what the guidelines will mean for people who have undergone surgery or who are taking medications that have been approved for weight management.

A study published in February in The New England Journal of Medicine found that people who had weight-based surgery as a means of weight control lost more weight than those who did not.

In addition, people who underwent weight-free surgery for a long time lost more body fat and lost more muscle mass.

People who have had surgery in the past had a greater risk of having a recurrence, according to the study.

There is no guarantee that surgery will work for everyone.

But for those who have not had weight reduction surgeries in the last few years, the FDA is looking at whether there is a need for further study, the Associated Press reported.

Read or Share this story: https://usat.ly/2jEzDfL